KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Interest & Investment Income (2017 - 2022)

Historic Interest & Investment Income for Sarepta Therapeutics (SRPT) over the last 8 years, with Q4 2022 value amounting to $9.1 million.

  • Sarepta Therapeutics' Interest & Investment Income rose 950631.58% to $9.1 million in Q4 2022 from the same period last year, while for Dec 2022 it was $16.5 million, marking a year-over-year increase of 455762.71%. This contributed to the annual value of $36.3 million for FY2023, which is 11989.93% up from last year.
  • As of Q4 2022, Sarepta Therapeutics' Interest & Investment Income stood at $9.1 million, which was up 950631.58% from $4.8 million recorded in Q3 2022.
  • In the past 5 years, Sarepta Therapeutics' Interest & Investment Income ranged from a high of $9.1 million in Q4 2022 and a low of -$7.0 million during Q3 2018
  • In the last 5 years, Sarepta Therapeutics' Interest & Investment Income had a median value of $160500.0 in 2021 and averaged $403400.0.
  • As far as peak fluctuations go, Sarepta Therapeutics' Interest & Investment Income plummeted by 388695.65% in 2018, and later surged by 950631.58% in 2022.
  • Quarter analysis of 5 years shows Sarepta Therapeutics' Interest & Investment Income stood at -$2.3 million in 2018, then soared by 164.04% to $1.5 million in 2019, then crashed by 95.2% to $71000.0 in 2020, then skyrocketed by 33.8% to $95000.0 in 2021, then surged by 9506.32% to $9.1 million in 2022.
  • Its last three reported values are $9.1 million in Q4 2022, $4.8 million for Q3 2022, and $2.4 million during Q2 2022.